This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4qpf
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4qpf is ON HOLD | + | The entry 4qpf is ON HOLD until Paper Publication |
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G. | Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G. | ||
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption | ||
Revision as of 08:17, 10 September 2014
Unreleased structure
The entry 4qpf is ON HOLD until Paper Publication
Authors: Ebetino, F.H., Lundy, M., Kwaasi, A.A., Dunford, J.E., Duan, Z., Triffitt, J., Mazur, A., Jeans, G., Barnett, B.L., Russell, R.G.G.
Description: New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption
